Stock Events

Stock Events

Exagen 

$7.91
23
+$0.13+1.67% 17:20 Today

Statistics

Day High
7.99
Day Low
7.62
52W High
12.23
52W Low
2.59
Volume
129,976
Avg. Volume
355,998
Mkt Cap
191.62M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.31
-0.25
-0.19
-0.13
Expected EPS
-0.18
Actual EPS
N/A

Financials

-29.97%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
66.58MRevenue
-19.95MNet Income

Analyst Ratings

9.57Average Price Target
The highest estimate is 12.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XGN. It's not an investment recommendation.
Apple
5
AAPL
NVIDIA
5
NVDA
JPMorgan Chase
5
JPM
PayPal
5
PYPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Quest Diagnostics
DGX
Mkt Cap25.87B
Quest Diagnostics offers diagnostic testing services, including those for autoimmune diseases, directly competing with Exagen's diagnostic solutions.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America provides comprehensive clinical laboratory services, including tests related to autoimmune diseases, similar to Exagen's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap9.53B
Bio-Rad Laboratories offers products and services for the life science research and clinical diagnostic markets, including autoimmune disease diagnostics.
Thermo Fisher Scientific
TMO
Mkt Cap217.52B
Thermo Fisher Scientific supplies analytical instruments, reagents and consumables, and software services, competing in the broader diagnostics and research market.
Danaher
DHR
Mkt Cap142.32B
Danaher Corporation operates businesses in the diagnostics sector, including autoimmune disease diagnostics, competing with Exagen's portfolio.
Bruker
BRKR
Mkt Cap8.79B
Bruker Corporation provides scientific instruments and solutions for molecular and materials research, as well as for diagnostics, including autoimmune disease areas.
Agilent Technologies
A
Mkt Cap41.95B
Agilent Technologies provides instruments, services, consumables, applications, and expertise, including in diagnostics and genomics, competing in the life sciences sector.
Illumina
ILMN
Mkt Cap28.82B
Illumina offers sequencing and array-based solutions for genetic and genomic analysis, competing in the broader market for diagnostics and research impacting autoimmune diseases.
Guardant Health
GH
Mkt Cap21.1B

About

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
Show more...
CEO
John Aballi
Employees
220
Country
United States
ISIN
US30068X1037
WKN
000A2PRXT

Listings

STU
DE
E08A.STU
MU
DE
E08A.MU
F
DE
E08A.F
XNAS
US
XGN

0 Comments

Share your thoughts

FAQ

What is Exagen stock price today?▼
The current price of XGN is $7.91 USD — it has increased by +1.67% in the past 24 hours. Watch Exagen stock price performance more closely on the chart.
What is Exagen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Exagen stocks are traded under the ticker XGN.
Is Exagen stock price growing?▼
XGN stock has risen by +19.07% compared to the previous week, the month change is a +63.17% rise, over the last year Exagen has showed a -20.54% decrease.
What is Exagen market cap?▼
Today Exagen has the market capitalization of 191.62M
When is the next Exagen earnings date?▼
Exagen is going to release the next earnings report on November 16, 2026.
What were Exagen earnings last quarter?▼
XGN earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.19 USD resulting in a +32.09% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Exagen revenue for the last year?▼
Exagen revenue for the last year amounts to 66.58M USD.
What is Exagen net income for the last year?▼
XGN net income for the last year is -19.95M USD.
How many employees does Exagen have?▼
As of August 21, 2026, the company has 220 employees.
In which sector is Exagen located?▼
Exagen operates in the Health & Wellness sector.
When did Exagen complete a stock split?▼
Exagen has not had any recent stock splits.
Where is Exagen headquartered?▼
Exagen is headquartered in VISTA, United States.